Joffre B. Baker
56Patents
17h-index
37Co-inventors
84Inventor score
Filing activity: Mar 13, 1987 → Aug 23, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7081340B2 | Gene expression profiling in biopsied tumor tissues | Chemistry; Metallurgy | 133 | Expired |
| US5534615A | Cardiac hypertrophy factor and uses therefor | Emerging Cross-Sectional Technologies | 115 | Expired |
| US7056674B2 | Prediction of likelihood of cancer recurrence | Chemistry; Metallurgy | 106 | Expired |
| US7930104B2 | Predicting response to chemotherapy using gene expression markers | Physics | 85 | Active |
| US5278049A | Recombinant molecule encoding human protease nexin | Human Necessities | 59 | Expired |
| US7767391B2 | Use of intronic RNA to measure gene expression | Chemistry; Metallurgy | 47 | Expired |
| US7695913B2 | Gene expression markers for colorectal cancer prognosis | Chemistry; Metallurgy | 34 | Active |
| US7871769B2 | Gene expression markers for predicting response to chemotherapy | Physics | 32 | Active |
| US7569345B2 | Gene expression markers for breast cancer prognosis | Chemistry; Metallurgy | 31 | Expired |
| US7526387B2 | Expression profile algorithm and test for cancer prognosis | Chemistry; Metallurgy | 27 | Expired |
| US5451399A | [ALA IL-8].sub.77 and [SER IL-8].sub.72 as Leukocyte adhesion inhibitors | Human Necessities | 24 | Expired |
| US5571893A | Cardiac hypertrophy factor | Emerging Cross-Sectional Technologies | 21 | Expired |
| US7723033B2 | Prediction of likelihood of cancer recurrence | Chemistry; Metallurgy | 19 | Active |
| US7939261B2 | Expression profile algorithm and test for cancer prognosis | Chemistry; Metallurgy | 19 | Active |
| US8067178B2 | Gene expression markers for prediction of patient response to chemotherapy | Physics | 18 | Active |
| US7622251B2 | Molecular indicators of breast cancer prognosis and prediction of treatment response | Physics | 18 | Expired |
| US5495001A | Recombinant purified protease nexin | Human Necessities | 17 | Expired |
| US8008003B2 | Gene expression profiling of EGFR positive cancer | Chemistry; Metallurgy | 16 | Expired |
| US5571675A | Detection and amplification of candiotrophin-1(cardiac hypertrophy factor) | Emerging Cross-Sectional Technologies | 15 | Expired |
| US7888019B2 | Genes involved estrogen metabolism | Chemistry; Metallurgy | 15 | Active |
| US7858304B2 | Gene expression profiling in biopsied tumor tissues | Chemistry; Metallurgy | 14 | Active |
| US5723585A | Method of purifying cardiac hypertrophy factor | Emerging Cross-Sectional Technologies | 14 | Expired |
| US8029995B2 | Gene expression markers for colorectal cancer prognosis | Chemistry; Metallurgy | 14 | Active |
| US5624806A | Antibodies to cardiac hypertrophy factor and uses thereof | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5627073A | Hybridomas producing antibodies to cardiac hypertrophy factor | Emerging Cross-Sectional Technologies | 14 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.